Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lubinski

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|December 3, 2013
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up studyC M Phelan, J Iqbal, H T Lynch, et al.
Breast Cancer Research and Treatment|May 11, 2006
XPD common variants and their association with melanoma and breast cancer riskT Debniak, R J Scott, T Huzarski, et al.
Journal of Medical Genetics|May 10, 2005
A common variant of CDKN2A (p16) predisposes to breast cancerT Debniak, B Górski, T Huzarski, et al.
Familial Cancer|October 24, 2003
The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative studyW Müller, L J Burgart, R Krause-Paulus, et al.
British Journal of Cancer|September 11, 2008
An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriersA Osorio, M Pollán, G Pita, et al.
Journal of Medical Genetics|July 5, 2005
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studiesA C Antoniou, P D P Pharoah, S Narod, et al.
American Journal of Human Genetics|April 5, 2003
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesA Antoniou, P D P Pharoah, S Narod, et al.
British Journal of Cancer|March 20, 2008
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsA C Antoniou, A P Cunningham, J Peto, et al.
Familial Cancer|September 19, 2009
Recommendations to improve identification of hereditary and familial colorectal cancer in EuropeH F A Vasen, G Möslein, A Alonso, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|December 3, 2013
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up studyC M Phelan, J Iqbal, H T Lynch, et al.
Breast Cancer Research and Treatment|May 11, 2006
XPD common variants and their association with melanoma and breast cancer riskT Debniak, R J Scott, T Huzarski, et al.
Journal of Medical Genetics|May 10, 2005
A common variant of CDKN2A (p16) predisposes to breast cancerT Debniak, B Górski, T Huzarski, et al.
Familial Cancer|October 24, 2003
The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative studyW Müller, L J Burgart, R Krause-Paulus, et al.
British Journal of Cancer|September 11, 2008
An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriersA Osorio, M Pollán, G Pita, et al.
Journal of Medical Genetics|July 5, 2005
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studiesA C Antoniou, P D P Pharoah, S Narod, et al.
American Journal of Human Genetics|April 5, 2003
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesA Antoniou, P D P Pharoah, S Narod, et al.
British Journal of Cancer|March 20, 2008
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsA C Antoniou, A P Cunningham, J Peto, et al.
Familial Cancer|September 19, 2009
Recommendations to improve identification of hereditary and familial colorectal cancer in EuropeH F A Vasen, G Möslein, A Alonso, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Pageof 9